Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
McKesson
Johnson and Johnson
Cipla
Argus Health
Harvard Business School

Generated: May 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,232,572

« Back to Dashboard

Which drugs does patent 7,232,572 protect, and when does it expire?

Patent 7,232,572 protects ORACEA and is included in one NDA.

This patent has nineteen patent family members in twelve countries.

Summary for Patent: 7,232,572
Title:Methods of treating rosacea
Abstract:A method of treating rosacea in a human in need thereof comprising administering to said human a tetracycline compound in an amount that is effective to treat rosacea, but has substantially no antibiotic activity.
Inventor(s): Ashley; Robert A. (Tucson, AZ)
Assignee: CollaGenex Pharmaceuticals, Inc. (Newtown, PA)
Application Number:11/061,866
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,232,572
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,232,572
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 7,232,572

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galderma Labs Lp ORACEA doxycycline CAPSULE;ORAL 050805-001 May 26, 2006 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial TREATMENT OF ONLY INFLAMMATORY LESIONS (PAPULES AND PUSTULES) OF ROSACEA ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Fish and Richardson
Federal Trade Commission
US Army
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.